Market revenue in 2023 | USD 184.5 million |
Market revenue in 2030 | USD 278.5 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.91% in 2023. Horizon Databook has segmented the Canada regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Canada has one of the largest numbers of biotechnology companies in the world with 732 biotech companies reported as of 2017 and is the largest market for the vaccine industry.
Canada’s regulatory environment is governed by Health Canada and there has been tremendous support by the government in encouraging investment for clinical development and manufacture of biopharmaceutical products.
Budget 2016 highlights a significant investment in Health Infoway and the Center for Drug Research and Development in the next two years, which is expected to attract many biopharmaceutical companies.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Canada regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account